{"id":15671,"date":"2022-01-19T20:50:40","date_gmt":"2022-01-19T19:50:40","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=15671"},"modified":"2022-01-19T20:50:40","modified_gmt":"2022-01-19T19:50:40","slug":"aza-ven-dans-la-vraie-vie-quelle-place-par-rapport-aux-chimiotherapies-intensives","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/aza-ven-dans-la-vraie-vie-quelle-place-par-rapport-aux-chimiotherapies-intensives\/","title":{"rendered":"AZA VEN dans la vraie vie : quelle place par rapport aux chimioth\u00e9rapies intensives ?"},"content":{"rendered":"<p>R\u00e9f :HematoStat.net ; 1 (12) : V31<\/p>\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34610123\/\"><em>Evan M Cherry<\/em><em>and al. Venetoclax and Azacitidine Compared to Induction Chemotherapy for Newly Diagnosed Patients with Acute Myeloid Leukemia. Blood Adv. 2021 Dec 28;5(24):5565-5573. Doi\u00a0: 10.1182\/bloodadvances.2021005538<\/em><\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>R\u00e9f :HematoStat.net ; 1 (12) : V31 Evan M Cherryand al. Venetoclax and Azacitidine Compared to Induction Chemotherapy for Newly Diagnosed Patients with Acute Myeloid Leukemia. Blood Adv. 2021 Dec [&hellip;]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[11],"tags":[223,217,61,224],"ppma_author":[442],"class_list":["post-15671","post","type-post","status-publish","format-standard","hentry","category-veille-bibliographique","tag-azacytidine-venetoclax","tag-chimiotherapie-intensive","tag-lam","tag-runx1","author-marion"],"aioseo_notices":[],"authors":[{"term_id":442,"user_id":2,"is_guest":0,"slug":"marion","display_name":"HematoStat.net (M)","avatar_url":{"url":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png","url2x":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png"},"first_name":"HematoStat.net (M)","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=15671"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15671\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=15671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=15671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=15671"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=15671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}